Results
|
1.
|
Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological Evaluation. [electronic resource] by
- Xue, Xiaoqian
- Zhang, Yan
- Liu, Zhaoxuan
- Song, Ming
- Xing, Yanli
- Xiang, Qiuping
- Wang, Zhen
- Tu, Zhengchao
- Zhou, Yulai
- Ding, Ke
- Xu, Yong
Producer: 20160726
In:
Journal of medicinal chemistry vol. 59
Availability: No items available.
|
|
2.
|
Discovery and optimization of novel N-benzyl-3,6-dimethylbenzo[d]isoxazol-5-amine derivatives as potent and selective TRIM24 bromodomain inhibitors with potential anti-cancer activities. [electronic resource] by
- Hu, Qingqing
- Wang, Chao
- Xiang, Qiuping
- Wang, Rui
- Zhang, Cheng
- Zhang, Maofeng
- Xue, Xiaoqian
- Luo, Guolong
- Liu, Xiaomin
- Wu, Xishan
- Zhang, Yan
- Wu, Donghai
- Xu, Yong
Producer: 20210225
In:
Bioorganic chemistry vol. 94
Availability: No items available.
|
|
3.
|
Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer. [electronic resource] by
- Xiang, Qiuping
- Zhang, Yan
- Li, Jiaguo
- Xue, Xiaoqian
- Wang, Chao
- Song, Ming
- Zhang, Cheng
- Wang, Rui
- Li, Chenchang
- Wu, Chun
- Zhou, Yulai
- Yang, Xiaohong
- Li, Guohui
- Ding, Ke
- Xu, Yong
Publication details: ACS medicinal chemistry letters Mar 2018
In:
ACS medicinal chemistry letters vol. 9
Availability: No items available.
|
|
4.
|
2-Amino-2,3-dihydro-1 [electronic resource] by
- Zhu, Dongsheng
- Huang, Huocong
- Pinkas, Daniel M
- Luo, Jinfeng
- Ganguly, Debolina
- Fox, Alice E
- Arner, Emily
- Xiang, Qiuping
- Tu, Zheng-Chao
- Bullock, Alex N
- Brekken, Rolf A
- Ding, Ke
- Lu, Xiaoyun
Producer: 20200622
In:
Journal of medicinal chemistry vol. 62
Availability: No items available.
|
|
5.
|
Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer. [electronic resource] by
- Xiang, Qiuping
- Wang, Chao
- Zhang, Yan
- Xue, Xiaoqian
- Song, Ming
- Zhang, Cheng
- Li, Chenchang
- Wu, Chun
- Li, Kuai
- Hui, Xiaoyan
- Zhou, Yulai
- Smaill, Jeff B
- Patterson, Adam V
- Wu, Donghai
- Ding, Ke
- Xu, Yong
Producer: 20180321
In:
European journal of medicinal chemistry vol. 147
Availability: No items available.
|
|
6.
|
Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer. [electronic resource] by
- Xue, Xiaoqian
- Zhang, Yan
- Wang, Chao
- Zhang, Maofeng
- Xiang, Qiuping
- Wang, Junjian
- Wang, Anhui
- Li, Chenchang
- Zhang, Cheng
- Zou, Lingjiao
- Wang, Rui
- Wu, Shuang
- Lu, Yongzhi
- Chen, Hongwu
- Ding, Ke
- Li, Guohui
- Xu, Yong
Producer: 20180619
In:
European journal of medicinal chemistry vol. 152
Availability: No items available.
|
|
7.
|
Structure-Based Discovery and Optimization of Benzo[ d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC). [electronic resource] by
- Zhang, Maofeng
- Zhang, Yan
- Song, Ming
- Xue, Xiaoqian
- Wang, Junjian
- Wang, Chao
- Zhang, Cheng
- Li, Chenchang
- Xiang, Qiuping
- Zou, Lingjiao
- Wu, Xishan
- Wu, Chun
- Dong, Baijun
- Xue, Wei
- Zhou, Yulai
- Chen, Hongwu
- Wu, Donghai
- Ding, Ke
- Xu, Yong
Producer: 20190417
In:
Journal of medicinal chemistry vol. 61
Availability: No items available.
|
|
8.
|
Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2- a]pyrazin-3-ylethynyl)-4-isopropyl- N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2. [electronic resource] by
- Wang, Zhen
- Zhang, Yali
- Pinkas, Daniel M
- Fox, Alice E
- Luo, Jinfeng
- Huang, Huocong
- Cui, Shengyang
- Xiang, Qiuping
- Xu, Tingting
- Xun, Qiuju
- Zhu, Dongsheng
- Tu, Zhengchao
- Ren, Xiaomei
- Brekken, Rolf A
- Bullock, Alex N
- Liang, Guang
- Ding, Ke
- Lu, Xiaoyun
Producer: 20191015
In:
Journal of medicinal chemistry vol. 61
Availability: No items available.
|
|
9.
|
Corrigendum: ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. [electronic resource] by
- Wang, Junjian
- Zou, June X
- Xue, Xiaoqian
- Cai, Demin
- Zhang, Yan
- Duan, Zhijian
- Xiang, Qiuping
- Yang, Joy C
- Louie, Maggie C
- Borowsky, Alexander D
- Gao, Allen C
- Evans, Christopher P
- Lam, Kit S
- Xu, Jianzhen
- Kung, Hsing-Jien
- Evans, Ronald M
- Xu, Yong
- Chen, Hong-Wu
Publication details: Nature medicine 06 2016
In:
Nature medicine vol. 22
Availability: No items available.
|
|
10.
|
ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. [electronic resource] by
- Wang, Junjian
- Zou, June X
- Xue, Xiaoqian
- Cai, Demin
- Zhang, Yan
- Duan, Zhijian
- Xiang, Qiuping
- Yang, Joy C
- Louie, Maggie C
- Borowsky, Alexander D
- Gao, Allen C
- Evans, Christopher P
- Lam, Kit S
- Xu, Jianzhen
- Kung, Hsing-Jien
- Evans, Ronald M
- Xu, Yong
- Chen, Hong-Wu
Producer: 20170809
In:
Nature medicine vol. 22
Availability: No items available.
|